EMERGENT BIOSOLUTIONS AND VALNEVA INITIATE PHASE 1 CLINICAL STUDY TO EVALUATE VACCINE CANDIDATE AGAINST ZIKA VIRUS
pharmaceutical investing Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update
